Search Clinical Trials
597,783 trials
ID
Status
Phase
Title
Sponsor
NCT07757256
Effect of Smart Watch Monitoring on Stress Levels Among Nursing Students During Older Adult Clinical Trainingdoaa mansour aliActive Not RecruitingNot Applicable
NCT07757256Active Not Recruiting
Not Applicable
Effect of Smart Watch Monitoring on Stress Levels Among Nursing Students During...doaa mansour ali
NCT07757880
Randomized Evaluation of Operating Room Extubation After Cardiac SurgeryBrigham and Women's HospitalNot Yet RecruitingNot Applicable
NCT07757880Not Yet Recruiting
Not Applicable
Randomized Evaluation of Operating Room Extubation After Cardiac SurgeryBrigham and Women's Hospi...
NCT07758283
Intergenerational Risk and Resilience of Rohingya in DisplacementInternational Centre for Diarrhoeal Disease Research, BangladeshActive Not Recruiting
NCT07758283Active Not Recruiting
—
Intergenerational Risk and Resilience of Rohingya in DisplacementInternational Centre for...
NCT07757932
Effects of a Wearable Postural Feedback Device on Scapular Muscle Endurance, Trunk Proprioception and Postural Awareness in Sedentary Office WorkersSaglik Bilimleri UniversitesiActive Not RecruitingNot Applicable
NCT07757932Active Not Recruiting
Not Applicable
Effects of a Wearable Postural Feedback Device on Scapular Muscle Endurance, Tru...Saglik Bilimleri Universi...
NCT07757698
A Prospective, Multicenter, Single-Arm Study to Support the Clinical Evidence Base for MRace as a Treatment Option for FMR Patients With Complex M-TEER Anatomies (AU)Polares Medical SANot Yet RecruitingNot Applicable
NCT07757698Not Yet Recruiting
Not Applicable
A Prospective, Multicenter, Single-Arm Study to Support the Clinical Evidence Ba...Polares Medical SA
NCT07756840
Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)National Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07756840Not Yet Recruiting
Phase 2
Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papil...National Cancer Institute...
NCT07758842
Lifestyle Modification for Erectile Dysfunction in Men With Metabolic SyndromeAl-Azhar UniversityNot Yet RecruitingNot Applicable
NCT07758842Not Yet Recruiting
Not Applicable
Lifestyle Modification for Erectile Dysfunction in Men With Metabolic SyndromeAl-Azhar University
NCT07759063
Clinical Validation of Self-Pacing Algorithms on Step Length Symmetry in Hemiplegic PopulationsQuality Living, Inc.Enrolling By InvitationNot Applicable
NCT07759063Enrolling By Invitation
Not Applicable
Clinical Validation of Self-Pacing Algorithms on Step Length Symmetry in Hemiple...Quality Living, Inc.
NCT07758452
Effectiveness of DIR/Floortime™ in Children With Intellectual Developmental DisorderGIFT UniversityCompletedNot Applicable
NCT07758452Completed
Not Applicable
Effectiveness of DIR/Floortime™ in Children With Intellectual Developmental Diso...GIFT University
NCT07758582
Validation of the Artificial Intelligence Subsystem of the DDART Medical Device for the Automated Detection of Lesions Compatible With Diabetic Retinopathy in a Random Sample of Retinal Fundus PhotographsDemocritus University of ThraceRecruiting
NCT07758582Recruiting
—
Validation of the Artificial Intelligence Subsystem of the DDART Medical Device...Democritus University of...
NCT07758634
A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With HypertensionCRISPR Therapeutics AGRecruitingPhase 1
NCT07758634Recruiting
Phase 1
A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants W...CRISPR Therapeutics AG
NCT07757074
A Comparative Study of Delayed Endoscopic DTI and Latissimus Dorsi ±Impalnt Reconstruction Post-MastectomyDu ZhengguiNot Yet Recruiting
NCT07757074Not Yet Recruiting
—
A Comparative Study of Delayed Endoscopic DTI and Latissimus Dorsi ±Impalnt Reco...Du Zhenggui
NCT07756957
Safety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Moderate to Severe AcneSanofi Pasteur, a Sanofi CompanyNot Yet RecruitingPhase 2
NCT07756957Not Yet Recruiting
Phase 2
Safety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Modera...Sanofi Pasteur, a Sanofi...
NCT07758803
A Randomized Controlled Trial Comparing the Effects of Different Anesthetic Sedatives on PONV in Laparoscopic CholecystectomyXi'an Aerospace General HospitalNot Yet RecruitingPhase 4
NCT07758803Not Yet Recruiting
Phase 4
A Randomized Controlled Trial Comparing the Effects of Different Anesthetic Seda...Xi'an Aerospace General H...
NCT07758920
A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Treatment of Postherpetic NeuralgiaShanghai Yidian Pharmaceutical Technology Development Co., Ltd.RecruitingPhase 2
NCT07758920Recruiting
Phase 2
A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Tr...Shanghai Yidian Pharmaceu...
NCT07757828
Efficacy of PRF in Hypospadias RepairAin Shams UniversityNot Yet RecruitingNot Applicable
NCT07757828Not Yet Recruiting
Not Applicable
Efficacy of PRF in Hypospadias RepairAin Shams University
NCT07757555
Guanfacine and Cromolyn Sodium for POTS: The DBPOTS TrialDysautonomia InternationalNot Yet RecruitingEarly Phase 1
NCT07757555Not Yet Recruiting
Early Phase 1
Guanfacine and Cromolyn Sodium for POTS: The DBPOTS TrialDysautonomia Internationa...
NCT07757594
FARES Versus Traction-Countertraction for Acute Anterior Shoulder DislocationNgoc Quyen LeNot Yet RecruitingNot Applicable
NCT07757594Not Yet Recruiting
Not Applicable
FARES Versus Traction-Countertraction for Acute Anterior Shoulder DislocationNgoc Quyen Le
NCT07758062
Levetiracetam Extended-Release Plus Stupp Protocol for Hypoxic IDH-Wildtype GlioblastomaTianjin Medical University General HospitalNot Yet RecruitingPhase 2
NCT07758062Not Yet Recruiting
Phase 2
Levetiracetam Extended-Release Plus Stupp Protocol for Hypoxic IDH-Wildtype Glio...Tianjin Medical Universit...
NCT07757048
A Study of Treatment Patterns and Real-World Outcomes in IgA Nephropathy Patients in the United StatesNovartis PharmaceuticalsCompleted
NCT07757048Completed
—
A Study of Treatment Patterns and Real-World Outcomes in IgA Nephropathy Patient...Novartis Pharmaceuticals
Result Breakdown
Not yet recruiting11 (55%)
Active, not recruiting3 (15%)
Recruiting3 (15%)
Completed2 (10%)
Enrolling by invitation1 (5%)
not_applicable9 (45%)
Not Specified4 (20%)
Phase 24 (20%)
Phase 11 (5%)
Phase 41 (5%)
Early Phase 11 (5%)